Barclay’s Capital
Barcelona
Clear all search history
Top Stories
Technology
Entertainment
Sports
More
Business
Politics
Law & Crime
Human Interest
Social Issues
Disasters & Accidents
Environment
Education
War & Conflict
Hospitality & Recreation
Health
Barclay’s Capital articles over last 30 days
-
articles last 30 days
-
articles per day
Mentioned in this news
Places
Companies
People
2012/05/17 17:20
2012/05/17 17:20
7d
Good Cholesterol May Not Lower Heart Risk: Study
... development of medicines such as Merck’s anacetrapib, an HDL booster that Tony Butler, a
Barclay’s Capital
analyst in New York, said on May 7 may generate $4 billion in peak revenue once...
Read more at
BusinessWeek
,
Medical News Today
,
+ 40 more articles
22808957
43
RELATED
Harvard Medical School
Sekar Kathiresan
The New York Times
Massachusetts General Hospital
Massachusetts General Hospital
MENTIONED
2012/05/17 17:20
2012/05/17 17:20
Latest videos
2012/05/17 17:20
2012/05/17 17:20
Latest from Twitter
2012/05/14 16:39
2012/05/14 16:39
10d
At midday: Greek uncertainty sends stocks tumbling
... credit supply, since demand for credit remains weak,” said Sreekala Kochugovindan at
Barclay’s Capital
in London. The energy sector lost 1.9 per cent as worries about falling demand...
Read more at
The Globe and Mail
,
Investment Executive
,
The Record
,
The Chronicle-Journal
,
+ 279 more articles
22591647
282
RELATED
Facebook
European Union
JPMorgan
Angela Merkel
Wal-Mart
MENTIONED
2012/05/07 12:42
2012/05/07 12:42
17d
A One-Two Punch Against Cystic Fibrosis, And Mayb...
... would work, may be cheered by the result. A recent note to clients by analysts at
Barclay’s Capital
said that an increase in FEV1 of 5% in the late stage study that would start next...
Read more at
Forbes
,
Boston Herald
,
KPLC Lake Charles
,
citybizlist Boston
,
+ 11 more articles
22146254
14
RELATED
VX-809
Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals
Cambridge
Vertex Pharmaceuticals Incorporated
MENTIONED
2012/04/29 09:52
2012/04/29 09:52
25d
Novo Nordisk to add 615 jobs
... three years after she was diagnosed as a type 2 diabetic. The company stands by her.
Barclay’s Capital
analyst Peter Bourdot downgraded the stock (NVO) last week because he was not sure...
Read more at Philly.com
Novo Nordisk
Jerzy Gruhn
Andy Ajello
Philadelphia Convention Center
American Diabetes Association
MENTIONED
Load more